Insider transaction
Jamie L. Reynoso, who serves as CEO of Medicare Advantage at Clover Health Investments, CORP. (NASDAQ:CLOV), disposed of 5,833 shares of the company’s Class A Common Stock on March 18, 2026. The aggregate proceeds from the sale amounted to approximately $11,141, with execution prices for the individual trades ranging between $1.87 and $1.96 per share. The disposition was carried out under a Rule 10b5-1 trading plan that Reynoso adopted on March 13, 2025.
Following the transaction, Reynoso retains direct ownership of 2,716,735 shares of Clover Health Investments, CORP.
Quarterly results and operational update
Clover Health reported fourth-quarter 2025 revenue of $487.2 million, a figure that the company says exceeded expectations by 4.31%. The company’s earnings per share for the quarter were reported at negative $0.1, a result described as in line with forecasts.
Separately, Clover Health announced that it has become the first health insurance payer to operate on a CMS Aligned Network and TEFCA. The company said this capability, implemented in collaboration with Kno2, allows Clover Health to respond to patient-directed requests for clinical and claims data using standardized FHIR formats. Clover also published a supplemental Q&A document intended to provide additional context for shareholders about its earnings announcement; that document is available on the investor relations section of Clover Health’s website.
Contextual notes
The sale by Reynoso was transacted under an existing 10b5-1 plan. The amounts, dates, and ownership levels reported above are as stated by the company. The company’s financial results and the new data-sharing capability are specific disclosures included in Clover Health’s recent communications to investors.
Where additional information is available
Investors seeking more detailed financial analysis and model-based insights can refer to platforms and resources that track CLOV’s financials and provide supplementary research tools. The supplemental Q&A referenced by the company is posted on Clover Health’s investor relations web pages.